Understand the bias, discover the truth in your news. Get Started
Economic Times Article Rating

TrumpRx website 2025: direct-to-consumer prescription drug platform and Pfizer discount deal explained

  • Bias Rating
  • Reliability

    60% ReliableAverage

  • Policy Leaning

    40% Somewhat Right

  • Politician Portrayal

    1% Positive

Bias Score Analysis

The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.

Sentiments

Overall Sentiment

14% Positive

  •   Liberal
  •   Conservative
SentenceSentimentBias
Unlock this feature by upgrading to the Pro plan.

Bias Meter

Extremely
Liberal

Very
Liberal

Moderately
Liberal

Somewhat Liberal

Center

Somewhat Conservative

Moderately
Conservative

Very
Conservative

Extremely
Conservative

-100%
Liberal

100%
Conservative

Bias Meter

Contributing sentiments towards policy:

69% : "The United States is done subsidizing the health care of the rest of the world," Trump said at a news conference.
68% : Also read: Pfizer shares jump 8% on Medicaid deal with Trump "This is a really big announcement," Trump said from the White House.
55% : In July, Trump sent letters to 17 major pharmaceutical company CEOs demanding compliance with the pricing model.
51% : Pfizer will begin offering Medicaid the reduced prices in early 2026.
51% : In May, Trump signed an executive order outlining the initiative, which directed federal officials to pursue a plan tying the amount the government pays for certain drugs to prices paid overseas.
51% : Trump has made reducing prescription drug costs a central goal since his first presidential campaign.
50% : Pfizer medications available on TrumpRx include: Trump stated that all new drugs introduced by Pfizer to the US market will be sold at the lower prices.
50% : " Trump acknowledged his actions may result in prices rising in other countries while coming down in America, calling that "fair.
50% : Also read: Pfizer gets three-year reprieve from Trump pharma tariffs "If this is all that President Trump does on drug pricing, it is likely a win for the pharmaceutical industry," Meekins said.
47% : Trump attempted to institute "most favored nation" pricing during his first term with an executive order to lower Medicare drug prices.
42% : Industry experts questioned whether TrumpRx will meaningfully reduce prescription drug costs for most Americans.
41% : "Importing foreign price controls would undermine American leadership, hurting patients and workers," Alex Schriver, senior vice president at PhRMA, said in a July statement.
38% : Also read: Trump to announce Pfizer price cuts as White House presses drugmakers Novo Nordisk announced last month that US patients can purchase a month's supply of Ozempic, the diabetes drug, for $499 for those paying without insurance.
28% : Trump suggested more deals with other drugmakers would follow but did not name specific companies.
25% : The announcement comes as the Trump administration has made significant cuts to Medicaid.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.

Category
Topic
Copy link